John Talley Turns His Attention to Cancer Therapy

John Talley Turns His Attention to Cancer Therapy

For Euclises, it’s simple. Without the work of John Talley, Ph.D., the world would not have Celebrex®, the blockbuster arthritis treatment that has generated in excess of $3.5 billion in sales for Pfizer. Or Dynastat®, an injectable COX-2 inhibitor that’s sold in... Read more